Your browser doesn't support javascript.
loading
Time lapses between distribution of influenza vaccines to health authorities and their administration by General Practitioners (GPs) to older adults: a retrospective study over five influenza seasons in Italy.
Lapi, Francesco; Marconi, Ettore; Fallani, Elettra; Salvatore, Marco; Cambiaggi, Maura; Rossi, Alessandro; Cricelli, Claudio.
Afiliación
  • Lapi F; Health Search, Italian College of General Practitioners and Primary Care, Florence, Italy.
  • Marconi E; Health Search, Italian College of General Practitioners and Primary Care, Florence, Italy.
  • Fallani E; Seqirus S.r.l. 53035, Monteriggioni, Siena, Italy.
  • Salvatore M; Department of Life Sciences; University of Siena, Siena, Italy.
  • Cambiaggi M; Seqirus S.r.l. 53035, Monteriggioni, Siena, Italy.
  • Rossi A; Department of Life Sciences; University of Siena, Siena, Italy.
  • Cricelli C; Seqirus S.r.l. 53035, Monteriggioni, Siena, Italy.
Expert Rev Vaccines ; 23(1): 8-15, 2024.
Article en En | MEDLINE | ID: mdl-38078867
ABSTRACT

BACKGROUND:

Delays in influenza vaccine delivery and administration can hinder vaccine coverage and protection. This study examines the differentials in distributing and administering adjuvanted trivalent (aTIV) and quadrivalent influenza vaccines (aQIV) to older adults in Italy's primary care setting and its potential impact on hospitalization risk over 5 epidemic seasons.

METHODS:

Using a primary care database, individuals aged ≥ 65 years were selected. The proportion of vaccine distribution to regional authorities and subsequent administration by GPs was estimated using census data. Using quantile (median) regression, we examined the relationship between velocities of vaccine distribution and administration (doses/week) and the incidence of hospitalizations.

RESULTS:

Over the 5 influenza seasons, the velocity of distribution and administration of aTIV/aQIV ranged 341-833 and 152-270 median doses/week; no trend was yielded for the difference between these velocities (p = 0.189) or vaccine coverage (p = 0.142). An association was observed for each differential dose/week between distributed and administered vaccines and all-cause hospitalizations with a 10% increase in 2017-2018, 54% in 2018-2019, and 12% in 2020-2021 season.

CONCLUSIONS:

These findings highlight the importance of minimizing the time lapse between vaccine distribution and administration to mitigate the impact of influenza and address factors that contribute to vaccination barriers.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas contra la Influenza / Gripe Humana / Médicos Generales Límite: Aged / Humans País/Región como asunto: Europa Idioma: En Revista: Expert Rev Vaccines Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas contra la Influenza / Gripe Humana / Médicos Generales Límite: Aged / Humans País/Región como asunto: Europa Idioma: En Revista: Expert Rev Vaccines Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Italia